The Online Investor

Slideshow Secondary Stock Offerings

By The Online Investor Staff, updated Sat., Sep. 19, 7:58 AM

Slide #16. 10x Genomics, Inc. Secondary Offering

Company: 10x Genomics, Inc. (NASDAQ:TXG)
Date announced: 9/10/2020
Shares Offered: 4,000,000
Date of Pricing: 9/10/2020
Price Per Share: $110.00
Secondary Offering Details: 10x Genomics, Inc. (NASDAQ: TXG) (the "Company") today announced the pricing of an upsized underwritten public offering by the Company of its Class A common stock at a price to the public of $110.00 per share, before underwriting discounts and commissions. 10x Genomics is offering 4,000,000 shares of its Class A common stock, plus up to an additional 600,000 shares of its Class A common stock that the underwriters have the right to purchase at the public offering price, less the underwriting discounts and commissions. All of the shares are being offered by the Company. The offering is expected to close on September 15, 2020, subject to customary closing conditions.

10x Genomics is a life science technology company building products to interrogate, understand and master biology. Co.'s product portfolio consists of multiple integrated solutions that include instruments, consumables and software. Co.'s Chromium platform, which includes its Chromium Controllers, microfluidic chips and related consumables, enables high-throughput analysis of individual biological components. Co.'s Visium platform enables researchers to understand the spatial positions of biological analytes within tissues at high resolution. Co.'s software is a part of its integrated solutions and is comprised of two parts, analysis and visualization.

TXG SEC Filing Email Alerts Service

Open the TXG Page at The Online Investor »

Company Name: 
10x Genomics Inc
Medical Instruments & Supplies
Number of ETFs Holding TXG: 
Total Market Value Held by ETFs: 
Total Market Capitalization: 
% of Market Cap. Held by ETFs: 

Open the TXG Page at The Online Investor (in a new window) »

Quotes delayed 20 minutes

Strong Buy (3.94 out of 4)
79th percentile
(ranked higher than approx. 79% of all stocks covered)
Based on Zacks ABR data;
powered by Xignite

Secondary Stock Offerings Page |

Copyright © 1998 - 2020, All Rights Reserved
Nothing in The Online Investor is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and stock market videos powered by Market News Video. Quote data delayed at least 20 minutes; data powered by Ticker Technologies, and Mergent. Contact The Online Investor; Meet Our Editorial Staff.